{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:45:44Z","timestamp":1790959544559,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pan.2025.02.014","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T12:12:02Z","timestamp":1740658322000},"page":"385-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inflammatory markers in predicting survival in pancreatic cancer: A Systematic review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Rinrada","family":"Worapongpaiboon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noppachai","family":"Siranart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5647-346X","authenticated-orcid":false,"given":"Patavee","family":"Pajareya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somkiat","family":"Phutinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pan.2025.02.014_bib2","series-title":"Global cancer Observatory: cancer today","author":"Ferlay","year":"2018"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"11","key":"10.1016\/j.pan.2025.02.014_bib4","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","article-title":"Update on the management of pancreatic cancer: surgery is not enough","volume":"21","author":"Ansari","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041101","article-title":"Prognosis of pancreatic cancer based on resectability: a single center experience","volume":"15","author":"Einama","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.pan.2025.02.014_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","article-title":"Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a seer Database analysis","volume":"27","author":"Sonbol","year":"2022","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/1319-3767.105927","article-title":"Pancreatic cystic neoplasms: predictors of malignant behavior and management","volume":"19","author":"Atef","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.pan.2025.02.014_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/apc.2019.06.01","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma","volume":"2","author":"Recio-Boiles","year":"2019","journal-title":"Ann Pancreat Cancer"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5114\/ceh.2019.87641","article-title":"Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct","volume":"5","author":"Luvira","year":"2019","journal-title":"Clin Exp Hepatol"},{"issue":"70","key":"10.1016\/j.pan.2025.02.014_bib10","doi-asserted-by":"crossref","first-page":"115561","DOI":"10.18632\/oncotarget.23310","article-title":"The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2025.02.014_bib11","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.12659\/MSM.907182","article-title":"Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resectable pancreatic neuroendocrine tumors","volume":"23","author":"Zhou","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pan.2025.02.014_bib12","article-title":"Prognostic value of preoperative NLR and vascular reconstructive technology in patients with pancreatic cancer of portal system invasion: a real world study","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.pan.2025.02.014_bib13","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.12659\/MSM.907182","article-title":"Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resectable pancreatic neuroendocrine tumors","volume":"23","author":"Zhou","year":"2017","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17885-y","article-title":"Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pan.2025.02.014_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fonc.2020.00583","article-title":"A simple model established by blood markers predicting overall survival after radical resection of pancreatic ductal adenocarcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib16","article-title":"Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cam4.204","article-title":"Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients","volume":"3","author":"Xue","year":"2014","journal-title":"Cancer Med"},{"issue":"50","key":"10.1016\/j.pan.2025.02.014_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009247","article-title":"Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients","volume":"96","author":"Xiao","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib19","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201190","article-title":"Neutrophil\u2013lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)","volume":"40","author":"Xiang","year":"2020","journal-title":"Biosci Rep"},{"issue":"26","key":"10.1016\/j.pan.2025.02.014_bib20","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.7150\/jca.30561","article-title":"A systematic inflammation-based model in advanced pancreatic ductal adenocarcinoma","volume":"10","author":"Wu","year":"2019","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/00015458.2018.1427329","article-title":"Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms","volume":"118","author":"Watanabe","year":"2018","journal-title":"Acta Chir Belg"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib22","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s12032-012-0226-8","article-title":"Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer","volume":"29","author":"Wang","year":"2012","journal-title":"Med Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01635581.2021.1903049","article-title":"Association of weight change, inflammation markers and disease staging with survival of patients undergoing chemotherapy for pancreatic adenocarcinoma","volume":"74","author":"Vasconcelos De Matos","year":"2022","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12029-020-00378-z","article-title":"Differences in baseline characteristics and white blood cell ratios between racial groups in patients with pancreatic adenocarcinoma","volume":"52","author":"Ueberroth","year":"2021","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/jcrt.JCRT_773_19","article-title":"The relation between inflammation-based parameters and survival in metastatic pancreatic cancer","volume":"17","author":"Turker","year":"2021","journal-title":"J Cancer Res Therapeut"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/000313481708300626","article-title":"Postoperative neutrophil-to-lymphocyte ratio as a predictor of long-term prognosis after pancreatectomy for pancreatic carcinoma: a retrospective analysis","volume":"83","author":"Tsujita","year":"2017","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12957-017-1169-5","article-title":"Predictive value of preoperative peripheral blood neutrophil\/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study","volume":"15","author":"Tong","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/cancers13061210","article-title":"The combination of neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio with liquid biopsy biomarkers improves prognosis prediction in metastatic pancreatic cancer","volume":"13","author":"Toledano-Fonseca","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12880-022-00823-4","article-title":"A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics","volume":"22","author":"Tian","year":"2022","journal-title":"BMC Med Imag"},{"issue":"8","key":"10.1016\/j.pan.2025.02.014_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.pan.2021.08.009","article-title":"Predictive factors of survival in patients with borderline resectable pancreatic cancer who received neoadjuvant therapy","volume":"21","author":"Tezuka","year":"2021","journal-title":"Pancreatology"},{"issue":"43","key":"10.1016\/j.pan.2025.02.014_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027591","article-title":"Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer","volume":"100","author":"Terao","year":"2021","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/030089161309900413","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapy","volume":"99","author":"Teo","year":"2013","journal-title":"Tumori Journal"},{"issue":"45","key":"10.1016\/j.pan.2025.02.014_bib33","doi-asserted-by":"crossref","first-page":"74314","DOI":"10.18632\/oncotarget.11031","article-title":"Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)","volume":"7","author":"Tao","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3109\/00365521.2015.1121515","article-title":"Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil\u2013lymphocyte ratio and immunohistochemical analyses of the tumour site","volume":"51","author":"Takakura","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"13","key":"10.1016\/j.pan.2025.02.014_bib35","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1245\/s10434-013-3227-8","article-title":"Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma","volume":"20","author":"Sugiura","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.2013.332","article-title":"Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer","volume":"109","author":"Stotz","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009707","article-title":"Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients","volume":"97","author":"Song","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1245\/s10434-016-5634-0","article-title":"Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer","volume":"24","author":"Sierzega","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s12029-019-00316-8","article-title":"The neutrophil-to-lymphocyte ratio is a prognostic biomarker in an ethnically diverse patient population with advanced pancreatic cancer","volume":"51","author":"Shusterman","year":"2020","journal-title":"J Gastrointest Cancer"},{"issue":"8","key":"10.1016\/j.pan.2025.02.014_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4251\/wjgo.v13.i8.915","article-title":"Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy","volume":"13","author":"Shin","year":"2021","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.pan.2025.02.014_bib41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/jcm8111791","article-title":"C-reactive protein and neutrophil\/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients","volume":"8","author":"Schlick","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12957-022-02606-1","article-title":"The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study","volume":"20","author":"Schlanger","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000527360","article-title":"Impact of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios on long-term survival in patients with operable pancreatic ductal adenocarcinoma","volume":"31","author":"Romano","year":"2022","journal-title":"Med Princ Pract"},{"issue":"12","key":"10.1016\/j.pan.2025.02.014_bib44","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1634\/theoncologist.2018-0786","article-title":"Long-term survivors in metastatic pancreatic ductal adenocarcinoma: a retrospective and matched pair analysis","volume":"24","author":"Rochefort","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3857\/roj.2021.01060","article-title":"Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy","volume":"40","author":"Reddy","year":"2022","journal-title":"Radiation Oncology Journal"},{"issue":"24","key":"10.1016\/j.pan.2025.02.014_bib46","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.7150\/jca.35856","article-title":"Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction","volume":"10","author":"Pu","year":"2019","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12885-020-07182-9","article-title":"Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma","volume":"20","author":"Pointer","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms18040730","article-title":"The neutrophil\/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients","volume":"18","author":"Piciucchi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.pan.2025.02.014_bib49","doi-asserted-by":"crossref","first-page":"18622","DOI":"10.1002\/cam4.6471","article-title":"A novel nomogram and risk classification system based on inflammatory and immune indicators for predicting prognosis of pancreatic cancer patients with liver metastases","volume":"12","author":"Peng","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jso.25629","article-title":"Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG)","volume":"120","author":"Panni","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.pan.2025.02.014_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1177271919851505","article-title":"Neutrophil to lymphocyte ratio is a predictive factor of malignant potential for intraductal papillary mucinous neoplasms of the pancreas","volume":"14","author":"Ohno","year":"2019","journal-title":"Biomark Insights"},{"issue":"8","key":"10.1016\/j.pan.2025.02.014_bib52","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/cancers15082367","article-title":"Inflammation-based prognostic scores in pancreatic cancer patients\u2014a single-center analysis of 1294 patients within the last decade","volume":"15","author":"Neumann","year":"2023","journal-title":"Cancers"},{"issue":"1\u20133","key":"10.1016\/j.pan.2025.02.014_bib53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.9738\/INTSURG-D-16-00129.1","article-title":"The values of several inflammatory markers, including the neutrophil\/lymphocyte ratio, in patients with pancreatic cancer treated by curative resection followed by adjuvant chemotherapy","volume":"105","author":"Nakayama","year":"2021","journal-title":"Int Surg"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/0973-1482.181181","article-title":"Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine\/nab-paclitaxel: results of a retrospective analysis","volume":"13","author":"Montes","year":"2017","journal-title":"J Cancer Res Therapeut"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12893-021-01178-3","article-title":"Increased neutrophil\u2013lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification","volume":"21","author":"Miura","year":"2021","journal-title":"BMC Surg"},{"issue":"17","key":"10.1016\/j.pan.2025.02.014_bib56","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/jcm11175084","article-title":"Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: a multicenter, prospective observational study","volume":"11","author":"Miki","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12029-022-00839-7","article-title":"Prognostic factors in resected pancreatic ductal adenocarcinoma: is neutrophil-lymphocyte ratio a useful marker?","volume":"54","author":"Merlo","year":"2023","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.08.016","article-title":"Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma","volume":"45","author":"McLellan","year":"2021","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib59","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3892\/ol.2017.5716","article-title":"Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors","volume":"13","author":"Luo","year":"2017","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib60","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1245\/s10434-014-4021-y","article-title":"Blood neutrophil\u2013lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy","volume":"22","author":"Luo","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","article-title":"Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution","volume":"20","author":"Li","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"7","key":"10.1016\/j.pan.2025.02.014_bib62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4251\/wjgo.v8.i7.555","article-title":"Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib","volume":"8","author":"Lee","year":"2016","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5009\/gnl17216","article-title":"The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are prognostic factors in patients with locally advanced pancreatic cancer treated with chemoradiotherapy","volume":"12","author":"Lee","year":"2018","journal-title":"Gut and Liver"},{"issue":"12","key":"10.1016\/j.pan.2025.02.014_bib64","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1007\/s00268-019-05159-9","article-title":"Prognostic impact of the neutrophil-to-lymphocyte ratio in borderline resectable pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiotherapy followed by surgical resection","volume":"43","author":"Kubo","year":"2019","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10147-015-0864-x","article-title":"Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy","volume":"21","author":"Kou","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"7\u20138","key":"10.1016\/j.pan.2025.02.014_bib66","article-title":"Prognostic impact of the combination of the neutrophil-to-lymphocyte ratio and serum carbohydrate antigen 19-9 in patients with pancreas head cancer","volume":"89","author":"Kim","year":"2019","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3904\/kjim.2018.076","article-title":"Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy","volume":"35","author":"Kim","year":"2020","journal-title":"Kor J Intern Med"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib68","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.surg.2018.12.015","article-title":"Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer","volume":"165","author":"Kawai","year":"2019","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.pan.2025.02.014_bib69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.21037\/jgo.2016.06.06","article-title":"Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer","volume":"6","author":"Kadokura","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75745-8","article-title":"Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer","volume":"10","author":"Iwai","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jjco\/hyu159","article-title":"Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan","volume":"45","author":"Inoue","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/ajco.13123","article-title":"Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma","volume":"15","author":"Ikuta","year":"2019","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib73","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10637-018-0681-y","article-title":"Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores","volume":"37","author":"Hwang","year":"2019","journal-title":"Invest N Drugs"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MPA.0000000000001202","article-title":"Diagnostic and prognostic impact of neutrophil-to-lymphocyte ratio for intraductal papillary mucinous neoplasms of the pancreas with high-grade dysplasia and associated invasive carcinoma","volume":"48","author":"Hata","year":"2019","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib75","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.pan.2019.08.003","article-title":"Prognostic significance of neutrophil\u2013lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages","volume":"19","author":"Harimoto","year":"2019","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12029-021-00683-1","article-title":"Does preoperative serum neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) predict prognosis following radical surgery for pancreatic adenocarcinomas? Results of a retrospective study","volume":"53","author":"Gupta","year":"2022","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib77","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.pan.2016.06.660","article-title":"Preoperative platelet-to-lymphocyte ratio improves the performance of the international consensus guidelines in predicting malignant pancreatic cystic neoplasms","volume":"16","author":"Goh","year":"2016","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jso.23997","article-title":"Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?","volume":"112","author":"Goh","year":"2015","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14701\/ahbps.2018.22.3.197","article-title":"Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma","volume":"22","author":"Giakoustidis","year":"2018","journal-title":"Annals of Hepato-Biliary-Pancreatic Surgery"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","article-title":"Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas","volume":"266","author":"Gemenetzis","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-017-6241-4","article-title":"Markers of systemic inflammatory response are prognostic factors in patients with pancreatic neuroendocrine tumors (PNETs): a prospective analysis","volume":"25","author":"Gaitanidis","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.pan.2025.02.014_bib82","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.21873\/anticanres.13013","article-title":"C-reactive protein-based prognostic measures are superior at predicting survival compared with peripheral blood cell count-based ones in patients after curative resection for pancreatic cancer","volume":"38","author":"Fujiwara","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pan.2025.02.014_bib83","first-page":"1","article-title":"White blood cell and granulocyte counts are independent predictive factors for prognosis of advanced pancreatic caner","volume":"2018","author":"Feng","year":"2018","journal-title":"Gastroenterology Research and Practice"},{"issue":"11","key":"10.1016\/j.pan.2025.02.014_bib84","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1007\/s00268-018-4686-7","article-title":"The prognostic value of preoperative neutrophil-to-lymphocyte ratio in resected patients with pancreatic adenocarcinoma","volume":"42","author":"Fang","year":"2018","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.pan.2025.02.014_bib85","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cancers13112771","article-title":"Involvement of neutrophils in metastatic evolution of pancreatic neuroendocrine tumors","volume":"13","author":"Debien","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib86","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.pan.2016.09.007","article-title":"The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients","volume":"16","author":"Cheng","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2025.02.014_bib87","article-title":"Competing risk analysis of outcomes of unresectable pancreatic cancer patients undergoing definitive radiotherapy","volume":"11","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.pan.2025.02.014_bib88","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.7150\/ijms.46254","article-title":"Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio","volume":"17","author":"Chen","year":"2020","journal-title":"Int J Med Sci"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.hpb.2017.10.011","article-title":"Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer","volume":"20","author":"Chawla","year":"2018","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/cancers11010057","article-title":"Prognostic factors for advanced pancreatic cancer treated with gemcitabine plus S-1: retrospective analysis and development of a prognostic model","volume":"11","author":"Chang","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib91","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4103\/jcrt.JCRT_366_19","article-title":"Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer","volume":"16","author":"Cetin","year":"2020","journal-title":"J Cancer Res Therapeut"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.amjsurg.2009.08.041","article-title":"Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio","volume":"200","author":"Bhatti","year":"2010","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPA.0000000000000271","article-title":"Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma","volume":"44","author":"Ben","year":"2015","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00595-015-1206-3","article-title":"Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios","volume":"46","author":"Asari","year":"2016","journal-title":"Surg Today"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pan.2015.10.006","article-title":"Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer","volume":"16","author":"Asaoka","year":"2016","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib96","first-page":"408","article-title":"Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy","volume":"9","author":"Asama","year":"2018","journal-title":"Molecular and Clinical Oncology"},{"issue":"12","key":"10.1016\/j.pan.2025.02.014_bib97","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-015-2973-2","article-title":"The neutrophil-to-lymphocyte ratio predicts malignant potential in intraductal papillary mucinous neoplasms","volume":"19","author":"Arima","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib98","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/COC.0000000000000263","article-title":"Albumin and neutrophil-lymphocyte ratio (NLR) predict survival in patients with pancreatic adenocarcinoma treated with SBRT","volume":"41","author":"Alagappan","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"13","key":"10.1016\/j.pan.2025.02.014_bib99","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1245\/s10434-018-6761-6","article-title":"Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma","volume":"25","author":"Abe","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.pan.2025.02.014_bib100","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ejso.2018.04.022","article-title":"Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma","volume":"44","author":"Abe","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib101","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10147-017-1111-4","article-title":"Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors","volume":"22","author":"Arima","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib102","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41598-017-00859-5","article-title":"Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib103","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/gs-21-848","article-title":"Risk factors and prognostic index model for pancreatic cancer","volume":"11","author":"Huang","year":"2022","journal-title":"Gland Surg"},{"issue":"18","key":"10.1016\/j.pan.2025.02.014_bib104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.21037\/atm.2019.08.35","article-title":"A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma","volume":"7","author":"Ikuta","year":"2019","journal-title":"Ann Transl Med"},{"issue":"7","key":"10.1016\/j.pan.2025.02.014_bib105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.pan.2021.08.003","article-title":"Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: a multi-institutional retrospective study","volume":"21","author":"Itoh","year":"2021","journal-title":"Pancreatology"},{"issue":"10","key":"10.1016\/j.pan.2025.02.014_bib106","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.hpb.2021.04.001","article-title":"The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm","volume":"23","author":"Kim","year":"2021","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/tcr.2018.12.20","article-title":"Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma","volume":"8","author":"Li","year":"2019","journal-title":"Transl Cancer Res"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib108","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1159\/000181179","article-title":"A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours","volume":"9","author":"Sakka","year":"2009","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.pan.2025.02.014_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288033","article-title":"A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma","volume":"18","author":"Shimagaki","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2025.02.014_bib110","article-title":"The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer","author":"Shirai","year":"2023","journal-title":"Surg Today"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib111","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amjsurg.2007.12.057","article-title":"Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma","volume":"197","author":"Smith","year":"2009","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/JP9.0000000000000011","article-title":"Prognostic factors for disease-free survival in patients with pancreatic ductal adenocarcinoma after surgery: a single center experience","volume":"2","author":"Tian","year":"2019","journal-title":"Journal of Pancreatology"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib113","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.21873\/anticanres.15611","article-title":"Platelet to lymphocyte ratio correlates with carcinoma progression in pancreatic intra epithelial neoplasia","volume":"42","author":"Wagner","year":"2022","journal-title":"Anticancer Res"},{"issue":"41","key":"10.1016\/j.pan.2025.02.014_bib114","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.3748\/wjg.v25.i41.6248","article-title":"Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor","volume":"25","author":"Xu","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"25","key":"10.1016\/j.pan.2025.02.014_bib115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011002","article-title":"Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery","volume":"97","author":"Yu","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.pan.2025.02.014_bib116","doi-asserted-by":"crossref","first-page":"70","DOI":"10.20892\/j.issn.2095-3941.2017.0152","article-title":"A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms","volume":"15","author":"Lan","year":"2018","journal-title":"Cancer Biol Med"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib117","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib118","first-page":"256","article-title":"Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma","volume":"22","author":"Kawata","year":"1992","journal-title":"Jpn J Clin Oncol"},{"issue":"9255","key":"10.1016\/j.pan.2025.02.014_bib119","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib121","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib122","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.COC.0000017093.79897.DE","article-title":"Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis","volume":"26","author":"Alexandrakis","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib123","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s10147-016-0975-z","article-title":"The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases","volume":"21","author":"Arima","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jso.25484","article-title":"Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas","volume":"120","author":"Yang","year":"2019","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib125","first-page":"180","article-title":"Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma","volume":"119","author":"Demirci","year":"2018","journal-title":"Bratisl Lek Listy"},{"issue":"3","key":"10.1016\/j.pan.2025.02.014_bib126","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","article-title":"Prognostic value of the systemic immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic cancer","volume":"27","author":"Murthy","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.02.014_bib127","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00432-020-03361-0","article-title":"Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy","volume":"147","author":"Markus","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.pan.2025.02.014_bib128","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/1354750X.2010.491557","article-title":"Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer","volume":"15","author":"An","year":"2010","journal-title":"Biomarkers"},{"issue":"9","key":"10.1016\/j.pan.2025.02.014_bib129","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2025.02.014_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9745601","article-title":"Prognostic roles of inflammatory markers in pancreatic cancer: comparison between the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio","volume":"2018","author":"Oh","year":"2018","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.pan.2025.02.014_bib131","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6449","article-title":"Adipose saturation reduces lipotoxic systemic inflammation and explains the obesity paradox","volume":"7","author":"Khatua","year":"2021","journal-title":"Sci Adv"},{"issue":"19","key":"10.1016\/j.pan.2025.02.014_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194876","article-title":"Fatty pancreas is a risk factor for pancreatic cancer: a systematic review and meta-analysis of 2956 patients","volume":"15","author":"Lipp","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.pan.2025.02.014_bib133","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2023.05.034","article-title":"Amphipathic liponecrosis impairs bacterial clearance and causes infection during sterile inflammation","volume":"165","author":"Kostenko","year":"2023","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.pan.2025.02.014_bib134","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.21037\/jgo-20-118","article-title":"Global trends in pancreas cancer among Asia-Pacific population","volume":"12","author":"Ranganath","year":"2021","journal-title":"J Gastrointest Oncol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:20:17Z","timestamp":1748866817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390325000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1424390325000420"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2025.02.014","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers in predicting survival in pancreatic cancer: A Systematic review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2025.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}